Form S-1/A N2OFF, Inc.
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20250214/A822M22CZ22RBTOX222D2ZY2IKGDRZ22Z272
Filed on: February 14, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA grants priority review for Pfizer's Talzenna and Xtandi combo in prostate cancer
- Zoetis launches feline osteoarthritis drug in Canada and EU
- Ipsen acquires Memo Therapeutics, adding kidney transplant drug
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
